Under the Radar Screen: How Bugs Trick Our Immune Defenses

Similar documents
Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

HIV INFECTION: An Overview

HIV & AIDS: Overview

RAISON D ETRE OF THE IMMUNE SYSTEM:

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007

Human Immunodeficiency Virus

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.

Fig. 1: Schematic diagram of basic structure of HIV

Under the Radar Screen:

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

RAISON D ETRE OF THE IMMUNE SYSTEM:

Running Head: AN UNDERSTANDING OF HIV- 1, SYMPTOMS, AND TREATMENTS. An Understanding of HIV- 1, Symptoms, and Treatments.

HIV/AIDS. Biology of HIV. Research Feature. Related Links. See Also

L I F E S C I E N C E S

MedChem 401~ Retroviridae. Retroviridae

Section 6. Junaid Malek, M.D.

I. Bacteria II. Viruses including HIV. Domain Bacteria Characteristics. 5. Cell wall present in many species. 6. Reproduction by binary fission


Centers for Disease Control August 9, 2004

5/6/17. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Viruses (including HIV) Pathogens are disease-causing organisms

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

Page 32 AP Biology: 2013 Exam Review CONCEPT 6 REGULATION

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

Under the Radar Screen: How Bugs Trick Our Immune Defenses

How HIV Causes Disease Prof. Bruce D. Walker

Prokaryotic Biology. VIRAL STDs, HIV-1 AND AIDS

, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic

8/13/2009. Diseases. Disease. Pathogens. Domain Bacteria Characteristics. Bacteria Shapes. Domain Bacteria Characteristics

3. on T helper {cells / lymphocytes} ; 3. ACCEPT macrophages / dendritic cells / CD4 cells

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

Human Immunodeficiency Virus

19/06/2013. Viruses are not organisms (do not belong to any kingdom). Viruses are not made of cells, have no cytoplasm, and no membranes.

HUMAN IMMUNODEFICIENCY VIRUS

Acquired immune deficiency syndrome.

Micro 301 HIV/AIDS. Since its discovery 31 years ago 12/3/ Acquired Immunodeficiency Syndrome (AIDS) has killed >32 million people

There are approximately 30,000 proteasomes in a typical human cell Each proteasome is approximately 700 kda in size The proteasome is made up of 3

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

Viral Genetics. BIT 220 Chapter 16

Viral structure م.م رنا مشعل

Intrinsic cellular defenses against virus infection


Lecture 2: Virology. I. Background

HIV Infection and Epidemiology: Can There Be a Cure? Dr. Nedwidek

Herpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Dr. Ahmed K. Ali Attachment and entry of viruses into cells

Basis and Clinical Applications of Interferon

Immunodeficiency. (2 of 2)

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

Virology Introduction. Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment.

Virus and Prokaryotic Gene Regulation - 1

2) What is the difference between a non-enveloped virion and an enveloped virion? (4 pts)

Overview: Chapter 19 Viruses: A Borrowed Life

Some living things are made of ONE cell, and are called. Other organisms are composed of many cells, and are called. (SEE PAGE 6)

BIT 120. Copy of Cancer/HIV Lecture

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics

VIRUSES AND CANCER Michael Lea

levels of genes were separated by their expression levels; 2,000 high, medium, and low

Julianne Edwards. Retroviruses. Spring 2010

Pathogens and the immune system

Lentiviruses: HIV-1 Pathogenesis

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors

The Immune System. These are classified as the Innate and Adaptive Immune Responses. Innate Immunity

AP Biology. Viral diseases Polio. Chapter 18. Smallpox. Influenza: 1918 epidemic. Emerging viruses. A sense of size

General Principles of Endocrine Physiology

HS-LS4-4 Construct an explanation based on evidence for how natural selection leads to adaptation of populations.

Modeling and Simulation of HIV-1 Intracellular Replication

MID-TERM EXAMINATION

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

CURRENT DEVELOMENTS AND FUTURE PROSPECTS FOR HIV GENE THERAPY USING INTERFERING RNA-BASED STRATEGIES

VIRUSES. 1. Describe the structure of a virus by completing the following chart.

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

DIFFERENTIAL IMPACT OF HIV-1 PROTEASE INHIBITORS ON SUBSETS OF CD4+ T-LYMPHOCYTES

Cell Communication. Local and Long Distance Signaling

Immune System AP SBI4UP

7.013 Spring 2005 Problem Set 7

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za

Overview of primary HHV-8 infection

Recombinant Protein Expression Retroviral system

Antiviral Chemotherapy

Structure of HIV. Virion contains a membrane envelope with a single viral protein= Env protein. Capsid made up of Gag protein

CHAPTER 18: Immune System

A PROJECT ON HIV INTRODUCED BY. Abdul Wahab Ali Gabeen Mahmoud Kamal Singer

Unit 2: Lesson 2 Case Studies: Influenza and HIV LESSON QUESTIONS

C. Incorrect! MHC class I molecules are not involved in the process of bridging in ADCC.

Antigen Presentation to T lymphocytes

Medical Virology. Herpesviruses, Orthomyxoviruses, and Retro virus. - Herpesviruses Structure & Composition: Herpesviruses

Evidence of HIV-1 Adaptation to HLA- Restricted Immune Responses at a Population Level. Corey Benjamin Moore

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Identification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist

PATHOGENS AND DEFENCE AGAINST INFECTIOUS DISEASE. By: Stephanie, Emily, Cem, and Julie

Adaptive Immune System

227 28, 2010 MIDTERM EXAMINATION KEY

Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

Viruses. Picture from:

Computational Simulations of the Human Immunodeficiency Virus Rev-RRE RRE Complex

7.012 Quiz 3 Answers

Immunity and Infection. Chapter 17

Transcription:

Under the Radar Screen: How Bugs Trick Our Immune Defenses Session 7: Cytokines Marie-Eve Paquet and Gijsbert Grotenbreg Whitehead Institute for Biomedical Research

HHV-8 Discovered in the 1980 s at the beginning of the AIDS epidemic Gamma herpes virus that only occurs in humans Causes Kaposi s sarcoma (proliferation of vasculature), mostly in HIV patients HIV-1 Retrovirus (RNA genome) that causes AIDS T tropic or Macrophage tropic strains Enters target cells through CD4 and possibly other coreceptors.

Human immunodeficiency virus (HIV-1) Biology ENV p24, p6, p7, p17 : proteins encoded by the gag gene that provide structural elements of the virus Reverse transcriptase: transcribes the viral RNA into double-stranded DNA. Integrase: integrates the DNA produced by reverse transcriptase into the host's genome. Protease: HIV's gag and pol genes are produced as larger combination proteins and the specific protease used by HIV cleaves these into separate functional units. Gp120: Exposed on the surface of the viral envelope and binds to the CD4 receptor on any target cell that has such a receptor, particularly the helper T-cell. Gp41: glycoprotein is non-covalently bound to gp120, and provides assistance in fusion with the host cell Tat: "Trans-Activator of Transcription helps HIV reproduce by compensating for a defect in its genome: the HIV RNA initially has a hairpin-structured portion which prevents full transcription occurring. However, a small number of RNA transcripts will be made, which allow the Tat protein to be produced. Tat then binds to and phosphorylates cellular factors, eliminating the effect of the hairpin RNA structure and allowing transcription of the HIV DNA (Kim, 2001). This itself increases the rate of transcription, providing a positive feedback cycle. This in turn allows HIV to have an explosive response once a threshold amount of Tat is produced, a useful tool for defeating the body's response. Rev : "Regulator of Virion allows fragments of HIV mrna that contain a Rev Response Unit (RRE) to be exported from the nucleus to the cytoplasm. Nef: "Negative Regulatory Factor". The expression of Nef early in the viral life cycle ensures T cell activation and the establishment of a persistent state of infection. Nef also promotes the survival of infected cells by downmodulating the expression of several surface molecules important in host immune function. These include major histocompatibility complex-i (MHC I) and MHC II present on antigen presenting cells (APCs) and target cells,cd4 and CD28 present on CD4+ T cells. Vif: "Viral infectivity factor is essential for viral replication Vpr: "Viral Protein R" plays an important role in regulating nuclear import of the HIV-1 pre-integration complex Vpu: "Viral Protein U". Vpu is involved in viral budding, enhancing virion release from the cell. Vpx: "Viral Protein X". Is absent in the HIV-1 viral strain but can be found in HIV-2 and SIV.

Chemokines/Cytokines Small molecules secreted by cells (app. 8-20 Kda) Can have chemotactic effects on neighboring cells Can be induced during an immune response and have a pro-inflammatory effect Bind to plasma membrane receptors on their target cells

cytokines Name Cells Function IL-1 Macrophage T,Bcellactivation;fever;inflammation IL-2 T cells T cell proliferation IL-3 T cells Growth of many cell types IL-4 T cells B cell growth and differentiation IL-5 T cells B cell, eosinophil growth IL-6 macrophages, T cells B cell stimulation,inflammation IL-7 stromal cells Early B and T cell differentiation IL-8 macrophages Neutrophil (PMN)attraction IL-9 T cells mitogen IL-10 T cells Inhibits Th1 cytokine production IL-11 Bone marrow stroma Hematopoeisis IL-12 APC Stimulates T, NK cells IL-13 T cells Similar to IL-4 IL-14 dendritic cells,t cells B cell memory IL-15 T cells same as IL-2 IL-16 - - IFNa Most cells Anti-viral IFNb Most cells Anti-viral IFNg T, NK cells inflammation,activates macrophages TGFb macrophages,lymphocytes depends on target TNFa Macrophage Inflammation; tumor killing TNFb T cells Inflammation; tumor killing;enhance phagocytosis

Calcium release assay Fura-2 is a widely used UV-excitable fluorescent calcium indicator. Its structure is derived from EGTA (Ethylen glycolbis(beta-amino-ethyl ether)) that has also 4 COOH-groups to bind calcium. Upon calcium binding, the fluorescent excitation maximum of the indicator undergoes a blue shift from 363 nm (Ca2+-free) to 335 nm (Ca2+-saturated), while the fluorescence emission maximum is relatively unchanged at ~510 nm. The indicator is typically excited at 340 nm and 380 nm respectively and the ratio of the fluorescent intensities corresponding to the two excitations is used in calculating the intracellular concentrations. Fura-2 is a calcium chelator which means that it is able to bind Ca2+ so that the ions are not able to perform a reaction with anything and easily can be transported.

Pertussis toxin (ptx) interferes with the regulation of the eukaryotic adenylate cyclase complex. Normal regulation of adenylate cyclase activity in mammalian cells (Adenylate cyclase (AC) is activated normally by a stimulatory regulatory protein (Gs) and guanosine triphosphate (GTP); however the activation is normally brief because an inhibitory regulatory protein (Gi) hydrolyzes the GTP. Adenylate cyclase activated by pertussis toxin (The pertussis A subunit transfers the ADP ribosyl moiety of NAD to the membrane-bound regulatory protein Gi that normally inhibits the eukaryotic adenylate cyclase. The Gi protein is inactivated and cannot perform its normal function to inhibit adenylate cyclase. The conversion of ATP to cyclic AMP cannot be stopped.)

Paper 1 A Broad-Spectrum Chemokine Antagonist Encoded by Kaposi s Sarcoma-associated Herpes Virus Viruses can produce chemokines that are similar to human cytokines and produce antagonistic effects.

Questions Fig 3. Why add EDTA in the calcium release assay and what does the EDTA do? What does it mean if the calcium response induced by a cytokine is pertussis toxin dependant? Why look at the effect of vmip-ii on HIV entry when vmip-ii is an HHV8 expressed chemokine?

Paper 2 Identification of a major co-receptor for primary isolates of HIV-1 Viruses can also use the cytokine/chemokine receptor system as mode of entry into human cells.

Questions Fig 1. Is using a luciferase based assay adequate to measure infection/viral entry? Why use RT-PCR to look at the expression of CC-CKR-5 mrna rather than use Western blots and look at the protein levels. Is it advantageous to the virus to use a chemokine receptor to enter the target cell considering that cytokines secreted by our immune system can block it?